Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment ; volume:15 ; number:1 ; day:9 ; month:2 ; year:2024 ; pages:1-20 ; date:12.2024
Nature Communications ; 15, Heft 1 (9.2.2024), 1-20, 12.2024
- Klassifikation
-
Sozialwissenschaften, Soziologie, Anthropologie
- Urheber
-
Juul-Madsen, Kristian
Parbo, Peter
Ismail, Rola
Ovesen, Peter L.
Schmidt, Vanessa
Madsen, Lasse S.
Thyrsted, Jacob
Gierl, Sarah
Breum, Mihaela
Larsen, Agnete
Andersen, Morten N.
Romero-Ramos, Marina
Holm, Christian K.
Andersen, Gregers R.
Zhao, Huaying
Schuck, Peter
Nygaard, Jens V.
Sutherland, Duncan S.
Eskildsen, Simon F.
Willnow, Thomas E.
Brooks, David J.
Vorup-Jensen, Thomas
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-45627-y
- URN
-
urn:nbn:de:101:1-2404180712592.787438788033
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Juul-Madsen, Kristian
- Parbo, Peter
- Ismail, Rola
- Ovesen, Peter L.
- Schmidt, Vanessa
- Madsen, Lasse S.
- Thyrsted, Jacob
- Gierl, Sarah
- Breum, Mihaela
- Larsen, Agnete
- Andersen, Morten N.
- Romero-Ramos, Marina
- Holm, Christian K.
- Andersen, Gregers R.
- Zhao, Huaying
- Schuck, Peter
- Nygaard, Jens V.
- Sutherland, Duncan S.
- Eskildsen, Simon F.
- Willnow, Thomas E.
- Brooks, David J.
- Vorup-Jensen, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain
Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells
Origins of amyloid-β
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Selective amyloid-β lowering agents
Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates
Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β
![Development of conformation specific Amyloid-β [Amyloid-beta] antibodies](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Development of conformation specific Amyloid-β [Amyloid-beta] antibodies
EGCG directly targets intracellular amyloid-β(1-42) aggregates and promotes their lysosomal degradation
Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Copper mediated amyloid-β binding to Transthyretin
Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain
Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells
Origins of amyloid-β
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Selective amyloid-β lowering agents
Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates
Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β
Development of conformation specific Amyloid-β [Amyloid-beta] antibodies
EGCG directly targets intracellular amyloid-β(1-42) aggregates and promotes their lysosomal degradation
Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Copper mediated amyloid-β binding to Transthyretin
Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain
Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells
Origins of amyloid-β
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Selective amyloid-β lowering agents
Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates
Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β
Development of conformation specific Amyloid-β [Amyloid-beta] antibodies
EGCG directly targets intracellular amyloid-β(1-42) aggregates and promotes their lysosomal degradation
Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro